This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2 EV Loftus Jr & WJ Sandborn (2002) Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 31, 1–20.
4 BA Hendrickson , R Gokhale & JH Cho (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15, 79–94.
6 R Sullivan , JE Smith & NJ Rowan (2006) Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspect Biol Med 49, 159–170.
7 DL Williams , A Mueller & W Browder (1996) Glucan-based macrophage stimulators: a review of their anti-infective potential. Clin Immunother 5, 392–399.
9 DL Williams & IW Browder (1994) Development of natural product (1 → 3)-β-d-glucan polymers as immune-stimulating pharmaceuticals. Polymers Adv Technol 5, 529–534.
10 PJ Rice , EL Adams , T Ozment-Skelton , (2005) Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmacol Exp Ther 314, 1079–1086.
11 I Lavi , D Friesem , S Geresh , (2006) An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells. Cancer Lett 244, 61–70.
12 Y Tao , L Zhang & PC Cheung (2006) Physicochemical properties and antitumor activities of water-soluble native and sulfated hyperbranched mushroom polysaccharides. Carbohydr Res 341, 2261–2269.
15 V Vetvicka , BP Thorton & GD Ross (1996) Soluble β glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonised target cells. J Clin Invest 98, 50–61.
17 O Ardon , Z Kerem & Y Hadar (1998) Enhancement of lignin degradation and laccase activity in Pleurotus ostreatus by cotton stalk extract. Can J Microbiol 44, 676–680.
18 N Kodama , M Yamada & H Nanba (2001) Addition of Maitake D-fraction reduces the effective dosage of vancomycin for the treatment of Listeria-infected mice. Jpn J Pharmacol 87, 327–332.
20 F Loher , C Bauer , N Landauer , (2004) The interleukin-1β-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T-helper 1 T-cell activation. J Pharmacol Exp Ther 308, 583–590.
22 LA Dieleman , MJ Palmen , H Akol , (1998) Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114, 385–391.
24 BO Lim , SH Lee , DK Park , (2003) Effect of dietary pectin on the production of immunoglobulins and cytokines by mesenteric lymph node lymphocytes in mouse colitis induced with dextran sulfate sodium. Biosci Biotechnol Biochem 67, 1706–1712.
25 L Liu , ZP Wang , CT Xu , (2003) Effects of Rheum tanguticum polysaccharide on TNBS-induced colitis and CD4+T cells in rats. World J Gastroenterol 9, 2284–2288.
27 HL Chung , GG Yue , KF To , (2007) Effect of Scutellariae Radix extract on experimental dextran-sulfate sodium-induced colitis in rats. World J Gastroenterol 13, 5605–5611.
28 A Nusrat , CA Parkos , TW Liang , (1997) Neutrophil migration across model intestinal epithelia: monolayer disruption and subsequent events in epithelial repair. Gastroenterology 113, 1489–1500.
29 M Nakamura , H Saito , J Kasanuki , (1992) Cytokine production in patients with inflammatory bowel disease. Gut 33, 933–937.
32 WE Pullman , S Elsbury , M Kobayashi , (1992) Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology 102, 529–537.
33 Y Raab , Y Raab , B Gerdin , (1993) Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut 34, 1203–1206.
35 A Akazawa , I Sakaida , S Higaki , (2002) Increased expression of tumor necrosis factor α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase. J Gastroenterol 37, 345–353.
36 T Olsen , R Goll , G Cui , (2007) Tissue levels of tumor necrosis factor-α correlates with grade of inflammation in untreated ulcerative colitis. Scand J Gastroenterol 42, 1312–1320.
37 G Järnerot , E Hertervig , I Friis-Liby , (2005) Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 128, 1805–1811.
38 P Rutgeerts , WJ Sandborn , BG Feagan , (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353, 2462–2476.
39 Y Okada , Y Tsuzuki , J Miyazaki , (2006) Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid (DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial flora and lymphocyte homing. Gut 55, 681–688.
41 ME McAlindon , CJ Hawkey & YR Mahida (1998) Expression of interleukin 1β and interleukin 1β converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut 42, 214–219.
43 D Rout , S Mondal , I Chakraborty , (2005) Chemical analysis of a new (1 → 3)-, (1 → 6)-branched glucan from an edible mushroom, Pleurotus florida. Carbohydr Res 340, 2533–2539.
44 JC Wang , SH Hu , ZC Liang , (2005) Optimization for the production of water-soluble polysaccharide from Pleurotus citrinopileatus in submerged culture and its antitumor effect. Appl Microbiol Biotechnol 67, 759–766.
45 S Melgar , MM Yeung , A Bas , (2003) Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol 134, 127–137.
46 C Asseman , S Mauze , MW Leach , (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190, 995–1003.
49 L Wogensen , X Huang & N Sarvetnick (1993) Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin-10 in the islets of Langerhans. J Exp Med 178, 175–185.
50 B Balasa & N Sarvetnick (1996) The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. J Autoimmun 9, 283–286.
51 Y Furukawa , G Becker , JL Stinn , (1999) Interleukin-10 (IL-10) augments allograft arterial disease. Paradoxical effects of IL-10 in vivo. Am J Pathol 155, 1929–1939.
53 M Neissner & BA Volk (1995) Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RTPCR). Clin Exp Immunol 101, 428–435.
54 T Kucharzik , R Stoll & N Lügering (1995) Circulating anti-inflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 100, 452–456.